
This program discusses the origins of Oncolytic Immunotherapy (OI) research, and highlights how Amgen has recognized OI and is investigating ways to harness its potential when treating patients with cancer.
View Now

In this iPub® edition of Cancer Insights, UPMC CancerCenter, features three prominent physician-scientists, highlighting their most promising work.
View publication